A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

NCT05277168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-A1904

Sponsor

Jiangsu HengRui Medicine Co., Ltd.